In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients

被引:6
|
作者
VanDevanter, Donald R. [1 ]
Van Dalfsen, Jill M. [2 ]
Burns, Jane L. [3 ,4 ]
Mayer-Hamblett, Nicole [4 ,5 ]
机构
[1] Case Western Reserve Univ, Sch Med, Pediat, Cleveland, OH 44106 USA
[2] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA
[3] Univ Washington, Seattle Childrens Hosp, Infect Dis, Seattle, WA 98195 USA
[4] Univ Washington, Pediat, Seattle, WA 98195 USA
[5] Seattle Childrens Res Inst, Biomed Stat, Seattle, WA 98101 USA
关键词
cystic fibrosis; initial P aeruginosa; susceptibility;
D O I
10.1093/jpids/pit052
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Chronic antibiotic suppression of cystic fibrosis (CF) infections has increased in the United States, as has isolation of Pseudomonas aeruginosa with reduced antibiotic susceptibility. However, analysis of the susceptibilities of 193 initial P aeruginosa clinical isolates suggests that antibiotic susceptibilities are comparable with wild-type strains despite expanded antipseudomonal treatment in the CF community.
引用
收藏
页码:151 / 154
页数:4
相关论文
共 50 条
  • [1] Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Qin, Xuan
    Zhou, Chuan
    Zerr, Danielle M.
    Adler, Amanda
    Addetia, Amin
    Yuan, Shuhua
    Greninger, Alexander L.
    MSPHERE, 2018, 3 (02)
  • [2] Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients
    Rao, Priyanka
    McCaughan, John
    McCalmont, Mark
    Goldsmith, Colin E.
    Hall, Valerie
    Millar, B. Cherie
    McCann, Mary-Ann
    Downey, Damian G.
    Rendall, Jacqueline C.
    Elborn, J. Stuart
    Moore, John E.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (04) : 349 - 352
  • [3] Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates
    Tramper-Stranders, G. A.
    van der Ent, C. K.
    Molin, S.
    Yang, L.
    Hansen, S. K.
    Rau, M. H.
    Ciofu, O.
    Johansen, H. K.
    Wolfs, T. F. W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (06) : 567 - 574
  • [4] Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis
    Giugno, Hilda
    Castanos, Claudio
    Lubatti, Alberto
    Luis Pinheiro, Jose
    Hernandez, Claudia
    Gonzalez Pena, Hebe
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2010, 108 (02): : 141 - 147
  • [5] Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Islam, S.
    Oh, H.
    Jalal, S.
    Karpati, F.
    Ciofu, O.
    Hoiby, N.
    Wretlind, B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (01) : 60 - 66
  • [6] Low Rates of Pseudomonas aeruginosa Misidentification in Isolates from Cystic Fibrosis Patients
    Kidd, Timothy J.
    Ramsay, Kay A.
    Hu, Honghua
    Bye, Peter T. P.
    Elkins, Mark R.
    Grimwood, Keith
    Harbour, Colin
    Marks, Guy B.
    Nissen, Michael D.
    Robinson, Philip J.
    Rose, Barbara R.
    Sloots, Theo P.
    Wainwright, Claire E.
    Bell, Scott C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (05) : 1503 - 1509
  • [7] Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration -: Lack of association in cystic fibrosis
    Smith, AL
    Fiel, SB
    Mayer-Hamblett, N
    Ramsey, B
    Burns, JL
    CHEST, 2003, 123 (05) : 1495 - 1502
  • [8] Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients
    Wagner, T
    Soong, G
    Sokol, S
    Saiman, L
    Prince, A
    CHEST, 2005, 128 (02) : 912 - 919
  • [9] Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
    Rees, Vanessa E.
    Lucas, Deanna S. Deveson
    Lopez-Causape, Carla
    Huang, Yuling
    Kotsimbos, Tom
    Bulitta, Jurgen B.
    Rees, Murray C.
    Barugahare, Adele
    Peleg, Anton Y.
    Nation, Roger L.
    Oliver, Antonio
    Boyce, John D.
    Landersdorfer, Cornelia B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [10] Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Artini, Marco
    Vrenna, Gianluca
    Trecca, Marika
    Assanti, Vanessa Tuccio Guarna
    Fiscarelli, Ersilia Vita
    Papa, Rosanna
    Selan, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)